1. Home
  2. DTIL

as 05-24-2024 3:32pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Founded: 2006 Country:
United States
United States
Employees: N/A City: DURHAM
Market Cap: 80.4M IPO Year: 2019
Target Price: $46.33 AVG Volume (30 days): 128.0K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -7.36 EPS Growth: N/A
52 Week Low/High: $8.25 - $27.00 Next Earning Date: 05-13-2024
Revenue: $57,531,000 Revenue Growth: 88.25%
Revenue Growth (this year): -48.92% Revenue Growth (next year): -12.05%

Share on Social Networks:

Stock Insider Trading Activity of Precision BioSciences Inc. (DTIL)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Scimeca Dario DTIL General Counsel and Secretary May 1 '24 Sell $10.32 272 $2,807.04 5,680 SEC Form 4
Amoroso Michael DTIL President and CEO May 1 '24 Sell $10.32 1,526 $15,748.32 13,772 SEC Form 4
List Alan DTIL Chief Medical Officer Apr 26 '24 Sell $10.03 238 $2,386.43 3,796 SEC Form 4
Scimeca Dario DTIL General Counsel and Secretary Jan 20 '24 Sell $0.36 21,287 $7,663.32 151,028 SEC Form 4
SMITH J. JEFFERSON DTIL Chief Research Officer Jan 20 '24 Sell $0.37 28,000 $10,360.00 1,987,269 SEC Form 4
List Alan DTIL Chief Medical Officer Jan 20 '24 Sell $0.36 21,526 $7,749.36 94,982 SEC Form 4
Scimeca Dario DTIL General Counsel and Secretary Nov 2 '23 Sell $0.40 16,023 $6,409.20 112,970 SEC Form 4
Kelly John Alexander DTIL Chief Financial Officer Aug 18 '23 Buy $0.48 90,000 $43,200.00 383,340 SEC Form 4